| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
57,544 |
53,003 |
$4.25M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
40,938 |
35,458 |
$1.77M |
| 80053 |
Comprehensive metabolic panel |
37,716 |
31,815 |
$1.23M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,609 |
6,002 |
$1.11M |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,627 |
5,454 |
$803K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,996 |
9,361 |
$649K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,344 |
4,811 |
$473K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,843 |
2,435 |
$318K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,113 |
5,184 |
$283K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,950 |
1,712 |
$215K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,241 |
1,102 |
$185K |
| 87070 |
|
8,872 |
8,333 |
$184K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,448 |
10,717 |
$106K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,485 |
1,392 |
$105K |
| 81001 |
|
19,190 |
16,965 |
$102K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15,346 |
12,798 |
$89K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,638 |
4,266 |
$87K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
913 |
784 |
$78K |
| 87040 |
|
2,811 |
2,049 |
$74K |
| G0378 |
Hospital observation service, per hour |
5,238 |
2,761 |
$63K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,695 |
3,225 |
$61K |
| 81003 |
|
9,227 |
8,327 |
$60K |
| 71045 |
Radiologic examination, chest; single view |
15,168 |
13,240 |
$59K |
| 71046 |
Radiologic examination, chest; 2 views |
5,660 |
5,220 |
$58K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,035 |
1,725 |
$56K |
| A9270 |
Non-covered item or service |
12,699 |
2,679 |
$53K |
| 76818 |
|
878 |
558 |
$48K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,013 |
2,650 |
$47K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,851 |
620 |
$46K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,321 |
3,867 |
$44K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,457 |
2,016 |
$42K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,131 |
1,618 |
$40K |
| 84703 |
|
11,298 |
10,324 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,563 |
4,533 |
$38K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
997 |
774 |
$29K |
| 12001 |
|
536 |
508 |
$27K |
| 84702 |
|
3,435 |
2,797 |
$24K |
| 85027 |
|
44,330 |
35,684 |
$24K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
22,066 |
18,874 |
$23K |
| 12011 |
|
386 |
369 |
$22K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
787 |
519 |
$22K |
| 73630 |
|
1,568 |
1,459 |
$21K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
407 |
322 |
$21K |
| 73130 |
|
1,393 |
1,255 |
$20K |
| 73610 |
|
1,362 |
1,277 |
$19K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
507 |
396 |
$18K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,305 |
1,200 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,095 |
9,702 |
$18K |
| 73030 |
|
1,020 |
867 |
$16K |
| 81025 |
|
3,961 |
3,732 |
$16K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
17,993 |
14,600 |
$16K |
| 74018 |
|
797 |
756 |
$16K |
| 73562 |
|
1,440 |
1,266 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,629 |
1,393 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,869 |
13,219 |
$15K |
| 87210 |
|
1,067 |
1,020 |
$14K |
| 73110 |
|
942 |
867 |
$14K |
| 72110 |
|
511 |
435 |
$13K |
| 86850 |
|
1,952 |
1,665 |
$13K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
587 |
458 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,578 |
1,520 |
$11K |
| S0028 |
Injection, famotidine, 20 mg |
1,972 |
1,784 |
$8K |
| 87807 |
|
2,492 |
2,429 |
$8K |
| 84484 |
|
12,606 |
8,712 |
$8K |
| 10060 |
|
108 |
99 |
$8K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
412 |
182 |
$8K |
| 93971 |
|
717 |
621 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,587 |
8,002 |
$7K |
| 85610 |
|
6,654 |
5,462 |
$6K |
| 73140 |
|
271 |
263 |
$6K |
| 84112 |
|
111 |
105 |
$6K |
| 70491 |
|
24 |
24 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,106 |
951 |
$6K |
| 76010 |
|
272 |
259 |
$6K |
| 74022 |
|
93 |
88 |
$6K |
| 85730 |
|
6,316 |
5,231 |
$5K |
| 84156 |
|
1,148 |
773 |
$5K |
| 86900 |
|
3,112 |
2,698 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,517 |
6,210 |
$5K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
85 |
83 |
$5K |
| 87186 |
|
2,232 |
1,900 |
$4K |
| 83880 |
|
2,733 |
2,297 |
$4K |
| 59025 |
Fetal non-stress test |
88 |
52 |
$4K |
| 76830 |
Ultrasound, transvaginal |
351 |
325 |
$4K |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
33 |
24 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,256 |
6,160 |
$4K |
| 70486 |
|
144 |
124 |
$4K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,154 |
1,820 |
$3K |
| 86901 |
|
3,117 |
2,695 |
$3K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
5,588 |
5,004 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
957 |
727 |
$3K |
| C1769 |
Guide wire |
216 |
169 |
$3K |
| 93970 |
|
32 |
27 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,594 |
1,981 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
707 |
298 |
$3K |
| 85379 |
|
1,811 |
1,649 |
$3K |
| 72131 |
|
31 |
26 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,753 |
2,120 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
510 |
449 |
$2K |
| 74019 |
|
25 |
25 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,541 |
1,372 |
$2K |
| 73090 |
|
135 |
128 |
$2K |
| 83690 |
|
10,598 |
9,415 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,325 |
6,829 |
$2K |
| 87205 |
|
501 |
395 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,584 |
1,526 |
$2K |
| 83735 |
|
4,618 |
3,746 |
$2K |
| 82570 |
|
998 |
735 |
$2K |
| 80143 |
|
810 |
712 |
$2K |
| 96376 |
|
1,770 |
1,166 |
$1K |
| 73502 |
|
76 |
67 |
$1K |
| 80076 |
|
902 |
738 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
451 |
368 |
$1K |
| 83605 |
|
2,080 |
1,722 |
$1K |
| 12002 |
|
12 |
12 |
$923.55 |
| 73080 |
|
90 |
79 |
$846.95 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,913 |
1,646 |
$842.12 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,843 |
2,907 |
$815.45 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
600 |
491 |
$700.64 |
| 73590 |
|
45 |
41 |
$693.04 |
| 80061 |
Lipid panel |
456 |
376 |
$486.10 |
| 84550 |
|
1,145 |
807 |
$485.14 |
| 90715 |
|
390 |
341 |
$485.07 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
617 |
525 |
$474.49 |
| 97162 |
|
12 |
12 |
$441.03 |
| 71101 |
|
12 |
12 |
$354.04 |
| 84439 |
|
61 |
52 |
$315.69 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,341 |
2,026 |
$293.52 |
| 84145 |
|
109 |
85 |
$285.35 |
| J1644 |
Injection, heparin sodium, per 1000 units |
271 |
139 |
$262.62 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
13 |
12 |
$225.46 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,101 |
2,949 |
$223.44 |
| 82550 |
|
144 |
123 |
$199.03 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
17 |
$193.55 |
| 81050 |
|
194 |
159 |
$183.65 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
57 |
13 |
$143.13 |
| 36415 |
Collection of venous blood by venipuncture |
507 |
381 |
$112.57 |
| J7050 |
Infusion, normal saline solution, 250 cc |
768 |
511 |
$109.87 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
58 |
53 |
$95.00 |
| 29125 |
|
49 |
48 |
$79.12 |
| 88307 |
|
14 |
12 |
$59.58 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
943 |
705 |
$58.27 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
164 |
101 |
$53.77 |
| J3490 |
Unclassified drugs |
16 |
12 |
$33.69 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
414 |
292 |
$20.27 |
| J2060 |
Injection, lorazepam, 2 mg |
838 |
659 |
$11.24 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
158 |
77 |
$6.98 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
57 |
40 |
$5.62 |
| 82248 |
|
71 |
52 |
$2.96 |
| 84100 |
|
46 |
39 |
$2.94 |
| 87075 |
|
39 |
25 |
$0.00 |
| 72070 |
|
14 |
13 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
56 |
40 |
$0.00 |
| C1758 |
Catheter, ureteral |
30 |
27 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
36 |
24 |
$0.00 |
| 87147 |
|
115 |
107 |
$0.00 |
| 86308 |
|
70 |
70 |
$0.00 |
| 86140 |
|
30 |
26 |
$0.00 |
| 85651 |
|
15 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
106 |
76 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
19 |
17 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
44 |
25 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
19 |
12 |
$0.00 |
| 82150 |
|
12 |
12 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
20 |
12 |
$0.00 |
| 72170 |
|
19 |
12 |
$0.00 |
| 88342 |
|
19 |
14 |
$0.00 |